Autres langues TARC Limited Bombay S.E.

Actions

TARC

INE0EK901012

Développement et opérations immobilières

Marché Fermé - Bombay S.E. 12:24:09 06/10/2026			Varia. 5j.	Varia. 1 janv.
124,30 ^INR	+1,47%		-1,82%	-26,75%

11/08	TARC Limited publie ses résultats pour le premier trimestre clos le 30 juin 2026	CI
09/07	TARC Limited annonce plusieurs nominations au sein de sa direction	CI

Autres langues

11/08	TARC Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
11/08	TARC Limited agreed to acquire remaining 50% stake in Niblic Greens Hospitality Pvt. Ltd. for INR 5.5 million.
09/07	TARC Limited Announces Executive Appointments
29/05	TARC Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
30/04	Tarc Ltd says Enforcement Directorate officials visit company premises on April 21, 2025
19/03	Tarc announces launch of Tarc Ishvara in Sector 63A, Gurugram
19/03	TARC Limited Announces Launch Of TARC Ishvara
07/02	TARC Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 30, 2025
12/01	TARC Limited Receives Addendum from Haryana Real Estate Regulatory Authority, Gurugram for Its Luxury Group Housing Development "TARC ISHVA"
11/11	TARC Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
10/10/25	Tarc achieves 5.65 billion rupees sales in H1 FY2026
12/08/25	TARC Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
29/07/25	Tarc says RERA registration received for project
30/05/25	TARC Widens Consolidated Net Loss in Fiscal Q4
29/05/25	TARC Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025
13/05/25	Apogee Therapeutics Announces Positive Interim Results from the Phase 1b Trial of APG808, its Novel Half-life Extended IL-4Ra Antibody, in Patients with Mild-to-Moderate Asthma
12/05/25	Apogee Therapeutics, Inc. Announces Positive Interim Results from the Phase 1B Trial of Apg808, Its Novel Half-Life Extended Il-4Ra Antibody, in Patients with Mild-To-Moderate Asthma
09/04/25	Tarc Achieves Highest Ever Annual Sales Of 37.22 Billion Rupees In FY2025
07/04/25	TARC Raises INR4.1 Billion through Debenture Allotment; Shares Down 7%
07/04/25	TARC Limited Approves the Allotment of 40,900 Debentures on Private Placement Basis
18/03/25	TARC Limited announced that it expects to receive INR 4.09 billion in funding
07/02/25	Tarc's Consolidated Loss Shrinks in Fiscal Q3
06/02/25	TARC Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024
03/02/25	TARC Limited Appoints Rita Misra as Chief Human Resources Officer
20/11/24	TARC Gets Board Nod to Raise Up To INR47 Billion